(Q50900159)

25 March 2018

title

Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatment. (English)

1 reference

25 March 2018

0 references

3

1 reference

25 March 2018

author name string

Dena Davidson

series ordinal

1

1 reference

25 March 2018

Philip W Wirtz

series ordinal

2

1 reference

25 March 2018

Richard Longabaugh

series ordinal

4

1 reference

25 March 2018

publication date

19 May 2007

1 reference

25 March 2018

published in

Psychopharmacology

1 reference

25 March 2018

volume

194

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

1-10

1 reference

25 March 2018

https://scigraph.springernature.com/pub.10.1007/s00213-007-0807-y

exact match

0 references

cites work

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0807-Y

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0807-Y

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-007-0807-Y

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

12 December 2020

Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence

1 reference

12 December 2020

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

12 December 2020

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

1 reference

12 December 2020

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

12 December 2020

Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes

1 reference

12 December 2020

How often is medication taken as prescribed? A novel assessment technique

1 reference

12 December 2020

Naltrexone in the treatment of alcoholism: predicting response to naltrexone

1 reference

12 December 2020

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

12 December 2020

Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications

1 reference

12 December 2020

Naltrexone as an adjunctive treatment for older patients with alcohol dependence

1 reference

12 December 2020

Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers

1 reference

12 December 2020

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

1 reference

12 December 2020

Predicting treatment response to naltrexone: the influence of craving and family history

1 reference

12 December 2020

Naltrexone in the treatment of alcoholism: a clinical review

1 reference

12 December 2020

Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting

1 reference

12 December 2020

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

12 December 2020

Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism

1 reference

12 December 2020

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

1 reference

12 December 2020

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

12 December 2020

Opioids and alcoholism

1 reference

12 December 2020

Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational-enhancement therapy for alcohol-dependent patients treated with naltrexone?

1 reference

12 December 2020

Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes

1 reference

12 December 2020

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

12 December 2020

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

1 reference

12 December 2020

Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.

1 reference

12 December 2020

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

12 December 2020

Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department.

1 reference

12 December 2020

Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies?

1 reference

12 December 2020

The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation.

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

1 reference

12 December 2020

10.1007/S00213-007-0807-Y

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018